Thrombectomy shown to aid heart attack patients
This article was originally published in Clinica
A recent study has suggested that Minneapolis, Minnesota-based Possis Medical's AngioJet thrombectomy treatment is beneficial in heart attack patients with large thrombus. The trial results show that when the AngioJet system is used to remove large thrombus before placement of a drug-eluting stent (DES), it is associated with significantly lower rates of death, repeat heart attack and stent thrombosis.
You may also be interested in...
Chief executive Eric Hobbs talks about the technology needed to accelerate antibody, cell therapy and synthetic biology, and prepare for the next pandemic.
A recent segment of CBS News “60 Minutes” discussing potential health benefits from probiotics was highly criticized by groups including the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the International Probiotics Association.
After a 12-month period that has seen Stada make significant investments in generics, biosimilars and consumer healthcare, CEO Peter Goldschmidt tells Generics Bulletin that the firm does not intend to stop there, as it pursues both organic and inorganic growth opportunities.